• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

1.080 UNCHANGED
Official Closing Price Updated: 8:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,619
Open 1.090
Bid (Size) 1.060 (200)
Ask (Size) 1.120 (200)
Prev. Close 1.080
Today's Range 1.050 - 1.090
52wk Range 1.030 - 27.84
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Blood Samples Could Be Used to Find Cancer-Specific Proteins Needed for Immunotherapy
October 02, 2026
Via Investor Brand Network
2 Billion Pounds of Cancer-Causing Chemicals Found Their Way into America in 2020
September 30, 2026
Via Investor Brand Network

Performance

52-Week Range 96.1% below 52-week high
1.080
1.0352W Low 27.8452W High
1 Week 4.4% below 1-week high
1.031W Low 1.131W High

Calidi Biotherapeutics, Inc. Common Stock (CLDI) traded between $1.03 and $27.84 over the past 52 weeks and last traded at $1.08, 96.1% below its 52-week high. Over the past week it ranged between $1.03 and $1.13.

Past 12 Months
+0.9%
-19.4%
-55.1%
-72.4%
-94.3%
-95.7%
1W +$0.01
1M -$0.26
3M -$1.32
6M -$2.84
YTD -$17.80
1Y -$23.88

CLDI was -95.7% over the past year, -72.4% over six months, -94.3% year to date, +0.9% in the last week.

12 Months vs Market
CLDI
-95.7%
DIA
+9.9%
SPY
+15.0%
QQQ
+23.7%
IWM
+15.4%

Over the past 12 months CLDI returned -95.7% versus DIA (Dow) +9.9%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +23.7% and IWM (Russell 2000) +15.4%.

Volume & Liquidity 0.15× 3-mo avg
Today 38,619 3-mo avg 259.8K
1W
60.3K
1M
203.6K
3M
259.8K
6M
317.8K
YTD
216.3K
1Y
164.3K

CLDI most recently traded 38,619 shares against a 3-month average daily volume of 259.8K.

More News

Read More
Why Treating Cancer is So Complicated
September 24, 2026
Via Investor Brand Network
Pancreatic Cancer Exploits Wound-Healing Mechanism to Evade Immune System
September 16, 2026
Via Investor Brand Network
Systemic Challenges in US Health Care Push Cancer Patients to Fly to China
September 15, 2026
Via Investor Brand Network
Biomarkers Could Predict Patients’ Response to Bladder Cancer Therapy
June 17, 2026
Via Investor Brand Network
Administering Immunotherapy Prior to Surgery Improves Brain Cancer Treatment Outcomes
September 03, 2026
Via Investor Brand Network
Boosting Thymus Health Could Improve Treatment Outcomes in Lung Cancer
September 02, 2026
Via Investor Brand Network
Personalized mRNA Vaccine Prevents Melanoma Recurrence, New Study Finds
August 25, 2026
Via Investor Brand Network
Mathematical Study Offers Possible Fix to Melanoma Therapy Mystery
August 19, 2026
Via Investor Brand Network
Little-Known Immune Cells Bolster Anticancer Fight, Study Finds
August 14, 2026
Via Investor Brand Network
Liquid Biopsy Forecasts Response to Immunotherapy in Lung Cancer Patients
August 06, 2026
Via Investor Brand Network
Existing Immune Protein May Boost Immunotherapy Against Cancer
August 05, 2026
Via Investor Brand Network
Researchers Plan to Investigate Role of Autoantibodies in Cancer Risk, Immune Response
July 28, 2026
Via Investor Brand Network
Dietary Fat Balance Could Influence Immune System Function, Study Finds
July 22, 2026
Via Investor Brand Network
Wondering what's happening in today's pre-market session? ↗
July 21, 2026
Via Chartmill
Top movers in Monday's after hours session ↗
July 20, 2026
Via Chartmill
Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity
July 17, 2026
Via Investor Brand Network
Understanding Why Treatment Resistance Exists in Many Cancers
July 09, 2026
Via Investor Brand Network
AI Tool Predicts the Optimal Presurgical Treatments for Breast Cancer
July 08, 2026
Via Investor Brand Network
Topics Artificial Intelligence
Comprehensive Review Shows Gut Microbiome Influences Immunotherapy Efficacy
July 02, 2026
Via Investor Brand Network
Currently Approved Drug Could Boost Immunotherapy Against Liver Cancer
June 30, 2026
Via Investor Brand Network
Why Men Need Sexual Health Help While Undergoing Cancer Treatment
June 22, 2026
Via Investor Brand Network
FIU Researchers Discover New Way of Extending Immune Cell Lifespan and Effectiveness
June 11, 2026
Via Investor Brand Network
News headline image
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
June 05, 2026
Via ACCESS Newswire

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 1.080
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 10/02/26 08:00 PM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 7.74M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 8M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap